Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. - Wikidata - awgldk - TriplyDB

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

http://www.wikidata.org/entity/Q37018223

about

Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency Oncogenic MicroRNAs: Key Players in Malignant Transformation MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer MicroRNAs and triple negative breast cancer Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation MicroRNAs as potential signatures of environmental exposure or effect: a systematic review The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.MicroRNA regulation of progesterone receptor in breast cancer Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum The expression pattern of microRNAs in granulosa cells of subordinate and dominant follicles during the early luteal phase of the bovine estrous cycle TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.MicroRNAs: short non-coding players in cancer chemoresistance.Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.miR-181c associates with tumor relapse of high grade osteosarcoma Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer MicroRNA-181a/b: novel biomarkers to stratify breast cancer patients for PARPi treatment The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination.Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells.microRNAs: a new class of breast cancer biomarkers.Targeting the microRNA-regulating DNA damage/repair pathways in cancer.Novel targets for ATM-deficient malignancies.Notch is a direct negative regulator of the DNA-damage response.Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.The DNA-damage response to γ-radiation is affected by miR-27a in A549 cells.MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).T-cadherin is associated with prognosis in triple-negative breast cancer A TGFβ-miR-182-BRCA1 axis controls the mammary differentiation hierarchy MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.Comparative analysis of the microRNA transcriptome between yak and cattle provides insight into high-altitude adaptation.Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer.MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.MiR-181 family-specific behavior in different cancers: a meta-analysis view.

P2860

Q26752448-622813B8-4FB2-4C19-95D1-5F62145D7B29 Q26773316-7B49661F-B432-41DE-A436-4CD0DDC01135 Q26775086-7F02D122-C618-4068-AC75-3D9EC4F6A7AA Q26862716-6BCD8B79-1CB4-4374-BFD5-32F60DE41645 Q28066481-A9E34969-B92F-43F4-A7F2-ADC3768D7874 Q28072204-1AD0EC5B-E8B1-490C-9C60-574299A1500F Q28235715-721CE61C-6A40-4D95-B88D-16536CE51A92 Q28393390-EEF63C40-A79F-4DF4-9C20-9607D6A4F946 Q30883662-874530F7-CC5B-4048-AAE7-48A00221BD6D Q33688484-91BC55C5-CB24-4729-A2B5-EFCE0C091181 Q33824699-125BDDB2-AFBA-4FDE-AE51-82EB0C63B9EF Q34142608-E22462E5-DDE6-4A8C-95BA-924D6A0C4239 Q34518332-49EB84E5-A07F-47D7-987B-A2EB6D22B7B6 Q34765897-86738747-BA4F-43DA-BB5E-443C6BB7F5AF Q35125641-301A3B77-94AC-4245-9607-E3FCF8A13C86 Q35198369-4745D082-D16C-4071-9948-222EBEDFEFF3 Q35315559-CE19C3A2-6ED2-4BF6-88A1-78CD929237BB Q35673637-7AB03C9B-4120-4732-84DA-58C83B5FE3B1 Q35870127-D3DDE2F2-D86C-46C3-8334-E1E46C2EC464 Q35985784-B239E7B6-5119-4D11-B8C2-286F5F2B0B8D Q35987249-FA0BCC28-4455-4E38-9CB2-91DCC26146DF Q36140898-B1B9F98C-5F9C-4A2C-8936-12C121B7B152 Q37075883-2189AB04-05AD-4EEA-A644-731C5C22D296 Q37344777-44700583-EF0E-4F01-A755-8602D875F716 Q37600040-A05C7E1A-1C87-495B-B28F-E21806522997 Q38197675-66D2FD53-922D-4089-AC2B-62DADC8735A7 Q38246220-17C872F8-7C70-4A7A-8FE9-BC45DF3489A5 Q38866642-6FDF0ADB-0C07-49EE-895B-13A152247BD0 Q38884385-C3F1F620-7031-446A-9A04-655DFF39A746 Q39000232-618C4068-543A-43D8-A8DD-550634F549F5 Q39028436-3D8A9FDD-913F-4BEE-93A3-CAE9B53F0E49 Q39100694-E2387140-9B66-40B7-867A-4E711ED161D8 Q39137771-E2E69A08-FC03-478E-B438-72AA6624A3B1 Q41612892-C45A34E0-3C82-4113-97D4-00B0F1ADC93E Q41678438-56E33C6F-77FA-4D79-BB93-6FB2E058306D Q41760459-604877D1-5DA6-4F3B-BFE8-0AE1A537A7A7 Q43280516-94A1D6BC-FE93-44B9-A613-D0BFC0AA5883 Q47157998-1BAB2EB8-E6FC-4910-B4BC-818C66D9921A Q47633999-840F4CF5-41AE-49B4-9B39-AD0770F888E5 Q50073977-5C7EE0DC-2049-44FC-8B0A-C1592B5ED167

P2860

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

http://www.wikidata.org/entity/Q37018223

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

@en

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

@nl

type

label

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

@en

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

@nl

prefLabel

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

@en

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

@nl

P1433

Q37018223-1311C584-A9DD-46FC-A916-11AF2F2526C5

P1476

Q37018223-055F001F-22BE-4629-9CC7-D7F18C4BB8D9

P2093

Q37018223-166844EA-0DB0-4516-8FA2-DFD11CB212F3

Q37018223-2149A2EB-CA97-42A0-B3B0-E508869A7F26

Q37018223-B61F4E32-9442-4142-BA50-1FD9E4270F2D

P2860

Q37018223-0BFD2716-308A-4BB5-98F1-8B5C124005DF

Q37018223-0F511302-7976-4974-B36D-A0587A267BEF

Q37018223-0FDF691F-A926-4218-B512-374608DDB05D

Q37018223-1300C7C3-DBAA-4710-ADCA-0E830CC32C75

Q37018223-137758AE-4ABB-4BCD-8242-16288326F43A

Q37018223-1BBC3404-F7A4-4B8A-BFE4-A2C05C2CD646

Q37018223-20D71CC7-F3A5-40BA-93C6-08D43847020C

Q37018223-28E79274-865A-48CA-88C0-068E8517244D

Q37018223-2BDA767E-4384-4354-926C-FA1A2307FBB6

Q37018223-2D1169AE-FF26-481E-9761-5D203F9282CB

P304

Q37018223-914875AC-956D-43BC-BA16-B8612CC4B1C0

P31

Q37018223-B88A52AE-69BA-4F4E-AE51-D5587C2AC452

P356

Q37018223-1034403B-6ADD-4340-B094-FAA968B372F2

P433

Q37018223-B0C5FAD0-5F73-47FB-BB61-C72D59441E34

P478

Q37018223-2BA7903B-618C-4E84-98F6-1A3E7A4776AB

P50

Q37018223-05768F52-5841-496D-AA6E-C70E69A25046

Q37018223-0F26A114-BE4B-411A-9B66-149FD62C0CE9

Q37018223-365584A9-4272-41FC-A7FC-1F7DD7EBC788

Q37018223-51D34D42-070E-46E6-ABC6-7A106F004695

Q37018223-55154567-C2B2-43EB-AA64-0128A0CDAC00

Q37018223-74D701E5-7010-4BBB-A318-3F919FE00995

Q37018223-9A7C9D94-44D2-4429-8272-4EC358D628BF

Q37018223-D7396E82-865D-4F9C-BC80-EFA457AFEB8F

P577

Q37018223-F05E36A1-26A2-4FFB-AFBB-298670214527

P5875

Q37018223-4C9669E0-492D-498B-AC49-1BAB69484FF2

P698

Q37018223-3CE26F48-03E1-41A8-A406-466590669F81

P921

Q37018223-8DA70BC2-B5E2-47E3-B5F9-7978FBF4C380

P932

Q37018223-444FC759-D47B-42C9-AC97-C5F62F1F33CB

P356

P1433

P1476

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer

@en

P2093

Jacopo De Santa

http://www.w3.org/2001/XMLSchema#string

Libero Santarpia

http://www.w3.org/2001/XMLSchema#string

Valeria Capaci

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma

Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNAs: target recognition and regulatory functions

In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma

A microRNA signature of hypoxia

Regulation of BRCA1 expression and its relationship to sporadic breast cancer

The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

PARP inhibitors stumble in breast cancer

P304

1679-1687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.24757

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Maria Grazia Daidone

Vera Cappelletti

Giannino Del Sal

Michela Faleschini

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236664993

http://www.w3.org/2001/XMLSchema#string

P698

23656790

http://www.w3.org/2001/XMLSchema#string

P921

P932

3713126

http://www.w3.org/2001/XMLSchema#string